ABI793
ABI793 is a human IgG1 anti-human CD154 (CD40 ligand) monoclonal antibody. ABI793 inhibits immune response by blocking the CD154-CD40 (IC50 = 75 nM) signaling pathway. ABI793 effectively prevents kidney transplant rejection. ABI793 can be used for research on immunological rejection.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform TNF Receptor
More
Activité biologique
Human
TNFSF5/CD40L/CD154
ABI793 inhibits CD154 and CD40 binding in a concentration dependent manner (IC50 = 75 nM)[1].
ABI793 (4 days) inhibits IL-4 stimulated B cell proliferation (IC50 = 73 nM)[1].
ABI793 (5 days) inhibits human mixed lymphocyte reaction (MLR) (IC50 = 320 ng/mL)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
ABI793 (20 mg/kg, i.v., on postoperative days 0, 1, 4, 11, 18, 28, 56, and 84) significantly prolongs the survival time of kidney transplantation in rhesus monkeys[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Renal allograft or autograft transplantation in Cynomolgus monkeys (3-8 kg)[1]
-
Dosage:20 mg/kg
-
Administration:Intravenous injection (i.v.) on postoperative days 0, 1, 4, 11, 18, 28, 56, and 84
-
Result:Significantly prolonged the survival time of transplanted kidneys (median survival of 108 days).
Did not cause acute tubular necro-sis (ATN) or thrombocytopenia in autograft transplantation.
-
Animal Model:Renal allograft transplantation in rhesus monkeys (4-6 years, 4-7 kg)[2]
-
Dosage:20 mg/kg
-
Administration:Intravenous injection (i.v.) on postoperative days 0, 1, 4, 11, 18, 28, 56, and 84
-
Result:Significantly prolonged kidney transplant survival time (median survival of 149 days).
Did not cause abnormal liver and kidney function or hematological toxicity.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
SMILES
N/A
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Schuler W, et al. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation. Transplantation. 2004 Mar 15;77(5):717-26. [Content Brief]
[2]. Kanmaz T, et al. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation. 2004 Mar 27;77(6):914-20. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
ABI793 Related Classifications
HY-P991557 Related Classifications
Powered by Bioz